What is the typical number of cycles of radiotherapy for a patient with glioma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Radiotherapy for Glioma: Number of Fractions

Radiotherapy for glioma is delivered in fractions over multiple weeks, not cycles—the specific fractionation schedule depends on glioma type, molecular markers, and patient characteristics, ranging from 15 to 33 fractions delivered over 3 to 6 weeks. 1

Standard Fractionation by Glioma Type

IDH-Wildtype Glioblastoma (Grade 4)

For newly diagnosed glioblastoma in patients under 70 years with good performance status:

  • 30 fractions: 60 Gy delivered as 2 Gy per fraction, 5 fractions per week over 6 weeks 1, 2
  • Concurrent temozolomide (75 mg/m² daily) is given throughout the 42-day radiation period 1, 2
  • Followed by adjuvant temozolomide for up to 6 cycles (150-200 mg/m² for 5 days every 28 days) 1, 2

For elderly patients (≥70 years) or those with poor performance status:

  • 15 fractions: 40-40.05 Gy delivered as 2.66-2.67 Gy per fraction over 3 weeks 1, 3
  • Concurrent temozolomide (75 mg/m² daily for 21 days) can be added 1
  • Followed by adjuvant temozolomide for up to 12 months 1

IDH-Mutant Lower Grade Gliomas

For IDH-mutant, 1p19q codeleted oligodendroglioma (Grade 2):

  • 30 fractions: 54 Gy delivered as 1.8 Gy per fraction over 6 weeks 1
  • Followed by 6 cycles of PCV chemotherapy (each cycle is 8 weeks) 1

For IDH-mutant, 1p19q codeleted anaplastic oligodendroglioma (Grade 3):

  • 33 fractions: 59.4 Gy delivered as 1.8 Gy per fraction, 5 fractions per week 1
  • Followed by 6 cycles of PCV or up to 12 months of temozolomide 1

For IDH-mutant, 1p19q non-codeleted astrocytoma (Grade 2 or 3):

  • 30 fractions (Grade 2): 54 Gy as 1.8 Gy per fraction over 6 weeks 1
  • 33 fractions (Grade 3): 59.4 Gy as 1.8 Gy per fraction 1
  • Followed by adjuvant temozolomide for up to 12 months 1

Critical Distinctions: Fractions vs. Cycles

Radiotherapy is measured in fractions (daily treatments), not cycles. 3 The term "cycles" applies to chemotherapy regimens that follow radiation:

  • PCV chemotherapy: 6 cycles total, each cycle lasting 8 weeks 1
  • Temozolomide maintenance: 6-12 cycles, each cycle lasting 28 days 1, 2

Treatment Volume Considerations

All modern glioma radiotherapy uses partial brain (focal) irradiation, not whole brain radiation. 1, 3, 4

  • Target volume includes tumor bed or resection site with 2-3 cm margin 1, 2
  • Whole brain radiotherapy is no longer recommended due to increased toxicity without survival benefit 4

Common Pitfalls to Avoid

Do not confuse radiation fractions with chemotherapy cycles—patients often ask "how many cycles of radiation," but radiation is delivered as daily fractions over consecutive weeks, while chemotherapy follows in distinct cycles. 2, 3

Lower dose radiation (45-50.4 Gy) is NOT inferior to higher doses (59.4-64.8 Gy) for low-grade gliomas and reduces toxicity, making it an acceptable alternative. 5, 4

Hypofractionated regimens (15 fractions) are specifically designed for elderly or frail patients—they are not simply "abbreviated" standard treatment but represent evidence-based dose-equivalent schedules. 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.